At the news
? BEARISHIMPACT 5/10 CLUSTER filed Mar 31, 2026 at 20:00 ET
Three senior executives at PTC Therapeutics sold shares in a concentrated 7-day window, including a $2.71M open-market sale by the Chief Technical Operations Officer. The total value of open-market sales reached $2.83M, representing 0.05% of the company's $5.8B market cap, with additional non-cash derivative exercises.
- Almstead Neil Gregory (Chief Technical Operations Officer) sold 39,400 shares at $68.89 for $2.71M in an open-market transaction.
- Boulding Mark Elliott (Exec VP and CLO) sold 822 shares at $68.91 for $56,644 and separately exercised 4,530 derivative securities (2,265 at $0, 2,265 at $39.42), resulting in $89,286 cash outlay.
- Golden Lee Scott (EVP & Chief Medical Officer) sold 829 shares at $67.99 for $56,364.
- Total open-market sale value: $2.83M over 7 days.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access